JIB 2010 Focuses on Human Health and Environment
By LabMedica International staff writers
Posted on 14 Oct 2010
The 55th Journées Internationales de Biologie (JIB) will take place on November 2-5, 2010, at the Centre des Nouvelles Industries et Technologies (CNIT; Paris, France). The scientific sessions will focus on improving understanding of the impact of the environment on human health.Posted on 14 Oct 2010
The aim of the sessions is to help biologists understand the physiological and pathological phenomena caused by changes in the environment. Chaired by Jean François Bach, permanent secretary of the Academy of Sciences, the scientific program will involve talks on subjects such as biologic response and adaptation mechanisms to the environment; autoimmunity and allergies; the environment and cardiovascular pathologies; the environment and reprotoxins; and nutrition, health and the environment.
The congress will present an opportunity for discussions on the French reform of the medical biology profession. Jean Benoit, President of the SDB [Union of Biologists], commented, "The scale of the task is immense but it gives biologists of all kinds the opportunity to redefine the contours of a profession at the forefront of technological innovation and one that anticipates the major evolutions in medicine.”
For the last three years, the JIB congress has highlighted molecular biology by devoting a space to it at the heart of the show. The molecular biology initiatives pavilion (BioMI) pavilion is dedicated to technologic advances in the process of detecting and curing pathological conditions. This year the JIB will welcome three new companies to the center: Bio Evolution (Italy), Coris Bioconcept (Gembloux, Belgium), and Laboratoires Nephrotek Sas (France).
A scientific session is being organized for BioMI that will be moderated by Prof. Michel Vidaud, head of the biochemistry and molecular genetics department of Beaujon hospital (Paris; France). The program will cover technologic innovations and discussions in areas such as applications of genomic techniques to diagnostics.
More than 1900 congress participants are expected and 96 presentations scheduled. There will be close to 200 exhibitors, including leaders from the in vitro diagnostics (IVD) sector, and an anticipated 10,000 visitors. One hundred and fifty-four new products have been announced and 114 of these will be launched at the show.
Related Links:
Journées Internationales de Biologie
Bio Evolution
Coris Bioconcept
Laboratoires Nephrotek Sas
Beaujon hospital